[A 2022 inventory in oncology news]. / Que retenir dans la prise en charge des cancers en 2022 ?
Bull Cancer
; 110(1): 19-31, 2023 Jan.
Article
in Fr
| MEDLINE
| ID: mdl-36529541
ABSTRACT
The Cancer Bulletin continues its tradition. At the beginning of 2023, the members of the editorial committee would like to share with you their analyses of the highlights of 2022. The objective remains to highlight what will change our practices and lead to different diagnostic or therapeutic options. Our synthesis will therefore focus on published data. They have been analyzed and placed in the more general context of the management of each type of cancer to deduce the practical consequences for our patients. This synthesis exercise will concern almost all tumor pathologies, most often on the therapeutic level, and will, however, exclude the evolution of techniques, whether they are diagnostic or used for the follow-up of our patients. The final objective is to allow you to have a thoughtful, didactic and practical reading. Our goal is to provide our readers with the rational bases that can lead to a different approach for treatments in 2023.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Medical Oncology
/
Neoplasms
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
Fr
Journal:
Bull Cancer
Year:
2023
Document type:
Article